Santhera Pharmaceuticals Holding AG/€SANN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG is a Swiss pharmaceutical company focused on the development and commercialization of innovative treatments for rare and debilitating diseases. The company's key areas of expertise include neuromuscular and pulmonary disorders. Santhera's product pipeline features several investigational drugs targeting conditions such as Duchenne muscular dystrophy and cystic fibrosis. Headquartered in Pratteln, Switzerland, the company leverages its scientific expertise and industry partnerships to advance its therapeutic offerings. Santhera's strategic focus on niche markets allows it to address unmet medical needs, providing potential opportunities for growth within specialized segments of the healthcare industry.
Ticker
€SANN
Sector
Primary listing
XGAT
Employees
94
Headquarters
Pratteln, Switzerland
Website
SANN Metrics
BasicAdvanced
€251m
-
-€4.10
-0.34
-
Price and volume
Market cap
€251m
Beta
-0.34
52-week high
€19.40
52-week low
€10.20
Average daily volume
7.3k
Financial strength
Current ratio
1.291
Quick ratio
0.78
Long term debt to equity
-288.609
Total debt to equity
-414.26
Interest coverage (TTM)
-3.25%
Profitability
EBITDA (TTM)
-35.29
Gross margin (TTM)
19.66%
Net profit margin (TTM)
-63.79%
Operating margin (TTM)
-48.73%
Effective tax rate (TTM)
-0.38%
Revenue per employee (TTM)
€889,410
Management effectiveness
Return on assets (TTM)
-15.64%
Return on equity (TTM)
-620.02%
Valuation
Price to revenue (TTM)
2.637
Price to book
-17.68
Price to tangible book (TTM)
-2.76
Price to free cash flow (TTM)
-5.842
Free cash flow yield (TTM)
-17.12%
Free cash flow per share (TTM)
-2.902
Growth
Revenue change (TTM)
97.32%
Earnings per share change (TTM)
2.44%
3-year revenue growth (CAGR)
117.78%
10-year revenue growth (CAGR)
33.41%
3-year earnings per share growth (CAGR)
-31.32%
10-year earnings per share growth (CAGR)
-9.96%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs